lobbying_activities: 1286626
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1286626 | 51582707-fac7-449c-9bbe-4dc9afedce73 | Q2 | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 292972 | BOEHRINGER INGELHEIM USA CORPORATION | 2012 | second_quarter | ANI | Illegal Compounding | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 466460 | 0 | 0 | 2012-07-20T15:31:05.407000-04:00 |